Literature DB >> 21185532

High prevalence of Pneumocystis jiroveci colonization among young HIV-infected patients.

Sonia Gutiérrez1, Rubén Morilla, Juan A León, Isabel Martín-Garrido, Laura Rivero, Vicente Friaza, Nieves Respaldiza, Marcos A Montes-Cano, Rafael Terán, Carmen de la Horra.   

Abstract

BACKGROUND: Pneumocystis colonization in young HIV-infected patients has been poorly studied. The aim of this study was to analyze the prevalence of P jiroveci colonization in a cohort of young HIV-infected patients.
MATERIAL AND METHODS: We designed a basal cross-sectional study in 20 young HIV-infected patients to determine the prevalence of P jiroveci colonization in oropharyngeal wash samples studied by nested polymerase chain reaction (PCR). Subsequently, patients were followed up during 50 weeks to observe the development of Pneumocystis pneumonia (PCP).
RESULTS: P jiroveci colonization was detected in eight (40%) of the 20 oropharyngeal wash samples. Genotype 85C/248C was the most frequent. After 50 weeks of follow-up, one colonized patient with advanced immunodepression developed PCP.
CONCLUSIONS: We have found a high prevalence of P jiroveci colonization in young HIV-infected patients with a major prevalence of genotype 1 (85C/248C). Further studies are necessary to clarify if Pneumocystis colonization could be a potential risk factor of developing PCP in young HIV infected patients.
Copyright © 2011 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21185532     DOI: 10.1016/j.jadohealth.2010.05.013

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  7 in total

1.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 2.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

Review 3.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation.

Authors:  Manoel Ortiz; Denise Soledade Jornada; Adriana Raffin Pohlmann; Sílvia Stanisçuaski Guterres
Journal:  AAPS PharmSciTech       Date:  2015-02-05       Impact factor: 3.246

5.  Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.

Authors:  Jonathan J Juliano; Eric Barnett; Christian M Parobek; Steve M Taylor; Steven R Meshnick; Stephen Stone; Emily Chang; Serena Fong; Laurence Huang
Journal:  Open Forum Infect Dis       Date:  2015-06-03       Impact factor: 3.835

6.  Pneumocystis pneumonia in South African children diagnosed by molecular methods.

Authors:  Brenda M Morrow; Catherine M Samuel; Marco Zampoli; Andrew Whitelaw; Heather J Zar
Journal:  BMC Res Notes       Date:  2014-01-10

Review 7.  Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.

Authors:  Xavier Iriart; Marine Le Bouar; Nassim Kamar; Antoine Berry
Journal:  J Fungi (Basel)       Date:  2015-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.